28 results
DEF 14A
ADPT
Adaptive Biotechnologies Corp
24 Apr 20
Definitive proxy
4:15pm
reputation or business, (5) the executive’s repeated failure or inability to perform any reasonable assigned duties after written notice
10-K
2019 FY
ADPT
Adaptive Biotechnologies Corp
26 Feb 20
Annual report
4:53pm
global portfolio of intellectual property rights to protect our immune medicine platform, the products and services that draw on it and our reputation … of these anti-bribery laws, or allegations of such violations, could have a negative impact on our business, results of operations and reputation. For instance
424B4
kfde 6898
24 Jan 20
Prospectus supplement with pricing info
4:49pm
DRS
2a7l2psv
9 Jan 20
Draft registration statement
12:00am
10-Q
EX-10.12
nt2ry u4aj
13 Aug 19
Quarterly report
4:36pm
8-K
EX-10.2
5o4raf
7 Aug 19
Adaptive Biotechnologies Executes Lease for New 100,000 Square Foot Corporate Headquarters, Tripling its Footprint in Seattle’s Growing Biotech Hub
5:29pm
424B4
ewbf1p
27 Jun 19
Prospectus supplement with pricing info
5:24pm
S-1
v2mk3lmq
30 May 19
IPO registration
5:20pm
S-1
EX-10.4
165va2xfxfftkqc7u
30 May 19
IPO registration
5:20pm
S-1
EX-10.15
b7z0beww5 o3u803
30 May 19
IPO registration
5:20pm
S-1
EX-10.11
xbz7hkvly oc
30 May 19
IPO registration
5:20pm
S-1
EX-10.18
ksw7jz0 zygtuzqf8
30 May 19
IPO registration
5:20pm